Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Company profile
Ticker
MLEC, MLECW
Exchange
Website
CEO
Mr. Gaston Paladini M.B.A.
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Lineage • Life Time • Waystar Holding • Noble • TKO • PACS • CERNER • MasterBrand • Veradigm • Concentra Group Holdings Parent ...
Former names
DHC Acquisition Corp.
SEC CIK
MLEC stock data
Latest filings (excl ownership)
20-F
2024 FY
Annual report (foreign)
30 Oct 24
6-K
Moolec Has Received USDA Approval For The First Genetically Modified Pea In History
16 Oct 24
6-K
Moolec Science Presents Fiscal Year 2024 Annual Business Update
4 Oct 24
S-8
Registration of securities for employees
20 Sep 24
6-K
Moolec Received Nasdaq Bid Price Letter
13 Sep 24
6-K
Moolec and Bunge Sign Research & Collaboration Agreement
9 Aug 24
6-K
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
15 Jul 24
424B3
Prospectus supplement
2 Jul 24
424B3
Prospectus supplement
2 Jul 24
6-K
Report of Foreign Private Issuer
28 Jun 24
Financial summary
| Quarter (USD) | Jun 24 | Jun 23 | Dec 22 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Jun 24 | Jun 23 | Dec 22 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
Institutional ownership, Q2 2024
| 13F holders | Current |
|---|---|
| Total holders | 32 |
| Opened positions | 29 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 251.48 mm |
| Total shares | 48.03 mm |
| Total puts | 0.00 |
| Total calls | 441.21 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BG Farming Technologies | 15.37 mm | $0.00 |
| Union Group Ventures | 15.17 mm | $0.00 |
| Bioceres | 12.45 mm | $0.00 |
| Biotech | 2.91 mm | $3.67 mm |
| Linden Advisors | 594.64 k | $30.33 mm |
| Aristeia Capital | 338.40 k | $17.26 mm |
| Baker Avenue Asset Management | 312.50 k | $81.25 mm |
| Davidson Kempner Capital Management | 250.00 k | $10.50 mm |
| Clear Street | 102.10 k | $5.00 k |
| Yakira Capital Management | 97.47 k | $4.87 mm |
News
Moolec Science Gains USDA Approval For Genetically Engineered Peas, Secures Milestone In Molecular Farming
16 Oct 24
Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
9 Oct 24
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
8 Oct 24
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
3 Oct 24
Press releases
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
16 Oct 24
Moolec Science Presents Fiscal Year 2024 Annual Business Update
2 Oct 24
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
25 Sep 24
Moolec Received NASDAQ Bid Price Letter
13 Sep 24